Medizinische Universität Graz - Research portal
Glawitsch Lisa |
Presentations at scientific and public conferences
Bauernhofer, ET; Moser, T; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer
ANN ONCOL. 2025; 36: -ESMO Congress 2025; OCT 17-21, 2025; Berlin, GERMANY.
Doi: 10.1016/j.annonc.2025.08.3135
[Poster]
Web of Science
FullText
FullText_MUG
Dobric, N; Suppan, C; Klocker, EV; Esterl, T; Moser, T; Hasenleithner, S; Beichler, C; Graf, R; Glawitsch, L; Weiss, L; Sandholzer, M; Steger, GG; Rinnerthaler, G; Heitzer, E; Jost, PJ; Balic, M; Dandachi, N
Pathogenic ESR1 alterations and co-alterations in HR+/HER2-advanced breast cancer
ANN ONCOL. 2025; 36: -ESMO Congress 2025; OCT 17-21, 2025; Berlin, GERMANY.
Doi: 10.1016/j.annonc.2025.08.934
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Beyond Blood? Assessing the prognostic and complementary role of urinary ctDNA in metastatic prostate cancer.
7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from Bench to Bedside”. 2025; -ACTC; SEP 24-27, 2025; Thessaloniki, GREECE.
[Poster]
Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Vlachos, G; Moser, MJ; Glawitsch, L; Hammer, S; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Beyond Blood: Can Urinary ctDNA Expand the Diagnostic Window in Advanced Prostate Cancer?
14th International Symposium on Circulating Nucleic Acids in Plasma and Serum. 2025; -CNAPS; DEC 3-5, 2025; Hong Kong, CHINA.
[Poster]
Vlachos, G; Sadeghi, H; Moser, T; Lazzeri, I; Moser, MJ; Glawitsch, L; Bauernhofer, ET; Eberhard, A; Beichler, C; Blatterer, J; Kühberger, S; Monsberger, N; Terbuch, A; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Functional Homologous Recombination Deficiency in Prostate Cancer Revealed Through Multimodal cfDNA Profiling.
14th CNAPS International Symposium, Hong Kong. 2025; -14th CNAPS International Symposium (CNAPS 2025); DEC 3-5, 2025; Hong Kong, CHINA.
[Poster]
Moser, T; Eberhard, A; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Lazzeri, I; Ziegler, L; Bauernhofer, E; Monsberger N; Geigl, JB; Bauernhofer, T; Heitzer, E
Linking liquids: cfDNA in urine and plasma as informative allies in metastasized prostate cancer.
Annual Meeting 2024. 2024; -AACR; APR 5-10, 2024; San Diego, USA.
[Poster]
FullText
Vlachos, G; Moser, T; Eberhard, A; Glaswitch, L; Blatterer, J; Bauernhofer, E; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Non-invasive detection of homologous recombination deficiency in metastatic prostate cancer patients.
Annual Meeting. 2024; -AACR 2024; APR 5-10, 2024; San Diego, USA;.
[Poster]
FullText
Eberhard, A; Moser, T; Hammer, S; Glawitsch, L; Ziegler, L; Vlachos, G; Lang, K; Lazzeri, I; Bauernhofer, T; Balic, M; Loibner, M; Heitzer, E
Development of analysis workflows for urinary cell-free DNA in malignant disease
Advances in Circulating Tumor Cells - ACTC 2023; SEP 20-23, 2023; Skiathos, Greece. 2023.
[Poster]
FullText
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E
Bridging urinary and plasma-based circulating tumor DNA analysis in prostate cancer.
Symposium of the Comprehensive Cancer Center. 2023; -CCC-Trio New Frontiers in Translational Oncology & Immuno-Oncology; APR 27-28, 2023; Vienna, AUSTRIA.
[Poster]
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E.
It's a match – ctDNA in urine and plasma reveal complementary information in prostate cancer.
13th International Symposium on Minimal Residual Cancer. 2023; -ISMRC; MAY 2-4, 2023; Hamburg, GERMANY.
[Poster]